Work

miRNAs as Theragnostic Markers for PARP Inhibitor Resistance in Breast Cancer: A Systematic Review

Year: 2026

Type: article

Study design: Systematic Review

Source: Current Cancer Drug Targets

DOI: 10.2174/0115680096450856260219065705

Authors: Mehran Molavand, Asal Golchin, Bahman Yousefi

Institutions: Tabriz University of Medical Sciences, Urmia University of Medical Sciences

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7142705246

FWCI:

Cites:

Cited by:

Related to: